News

Beactica scientists describe strategies for fragment-based drug discovery in two publications in Journal of Medicinal Chemistry. The research is a result of an international collaboration between Beactica, IOTA Pharmaceuticals Ltd, Cambridge, UK, and scientists at Uppsala University, Sweden.
Uppsala, Sweden, 4 February 2011 >Read more


© 2017 Synaptologics.com | Contact us